Heparin as a therapy for COVID-19: current evidence and future possibilities.
Saved in:
| Title: | Heparin as a therapy for COVID-19: current evidence and future possibilities. |
|---|---|
| Authors: | Hippensteel JA; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., LaRiviere WB; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Colbert JF; Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Langouët-Astrié CJ; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Schmidt EP; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Medicine, Denver Health Medical Center, Denver, Colorado. |
| Source: | American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2020 Aug 01; Vol. 319 (2), pp. L211-L217. Date of Electronic Publication: 2020 Jun 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Review |
| Journal Info: | Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901229 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1504 (Electronic) Linking ISSN: 10400605 NLM ISO Abbreviation: Am J Physiol Lung Cell Mol Physiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
